Test Price
2,700 AED✅ Home Collection Available
Respiratory Comprehensive Panel Test in UAE | 2,700 AED | DHA-Licensed Diagnostic Screening
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing, utilising multiplex real-time PCR and whole genome sequencing for definitive respiratory pathogen identification.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Certified phlebotomist dispatches specimens in validated 2-8°C containers to the laboratory within 4 hours.
- Clinical Guidance: Post-test telephonic interpretation support by a DHA-licensed general practitioner to correlate molecular findings with your clinical presentation and history.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731. Send your policy card for instant eligibility confirmation.
- Core Metric: Simultaneous detection of 30+ viral, bacterial, and fungal respiratory pathogens from a single specimen with actionable strain-level data within 48-72 hours.
Test Overview & Methodology
The Respiratory Comprehensive Panel is a next-generation molecular assay that combines multiplex quantitative PCR (qPCR) with whole genome sequencing (WGS) to deliver unparalleled breadth and depth in respiratory pathogen detection. Unlike conventional culture or single-target PCR tests that cover only 5–15 common organisms, this panel identifies over 30 viral, bacterial, and fungal targets—including rare and mutated strains—from a single throat swab, nasal swab, sputum, or bronchoalveolar lavage specimen. The dual methodology ensures both rapid detection via qPCR and high-resolution genotyping via WGS, enabling clinicians to tailor antimicrobial therapy, rule out co-infections, and monitor for resistance markers with confidence.
| Feature | Our Test (Respiratory Comprehensive Panel) | Closest Alternative (Standard Respiratory Panel) |
|---|---|---|
| Methodology | Multiplex qPCR + Whole Genome Sequencing | Single-target PCR or culture |
| Pathogens Detected | 30+ (including rare/mutated strains) | 5–15 common pathogens |
| Turnaround Time | 48–72 hours (Mon-Wed-Fri batch) | 3–7 days |
| Sample Types | Throat/Nasal swab, Sputum, BAL | Usually swab only |
Physician Insight & Safety Protocols
“In my clinical practice, the Respiratory Comprehensive Panel has been transformative for immunocompromised and critical patients where time and accuracy are essential. I always correlate the molecular findings with the patient’s symptoms and chest imaging to avoid misinterpretation of colonising flora. Please reach out after your report; we are here to guide your next steps with compassion and clinical precision.”
— Dr. Ajay Singh (DHA Registration ID: 36234132), General Practitioner
⚠ Medication Advisory
Do not discontinue prescribed medication (antibiotics, antivirals, inhalers, or immunosuppressants) without consulting your doctor. This test is a diagnostic aid, not a substitute for ongoing clinical management. Always share your complete medication list with the evaluating physician.
🚨 Safety Exclusion Criteria & Emergency Red Flags
- Home collection cannot be performed if you have: severe dyspnea at rest, oxygen saturation below 92%, or active hemoptysis.
- Seek emergency care immediately if you develop: worsening chest pain, bluish lips or face, confusion, or high fever unresponsive to antipyretics.
- Contraindication: Do not undergo the test solely for travel clearance; it must be part of a physician-directed diagnostic workup.
- Patients under 18 years must have parental or guardian consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability (Minors provisions).
Patient FAQ & Clinical Guidance
1. What is the accuracy of the Respiratory Comprehensive Panel for detecting COVID-19, influenza, and other respiratory viruses?
The panel demonstrates 99.9% diagnostic sensitivity for SARS-CoV-2, influenza A/B, RSV, and 25 other respiratory viruses when compared to gold-standard individual PCR assays. Its whole genome sequencing component further identifies viral lineage and potential antiviral resistance mutations, making it exceptionally reliable for guiding treatment in high-risk patients.
2. What does the sample collection involve, and how is cold-chain transport maintained?
A certified phlebotomist collects a throat or nasal swab (or sputum, if ordered) using a specialised viral transport medium that preserves nucleic acids. The specimen is immediately placed in a validated cold-chain container (2–8°C) and transported to our ISO-accredited laboratory within 4 hours, ensuring zero degradation and a 99.8% nucleic acid viability rate.
3. Can I use health insurance to cover the 2,700 AED cost, and how quickly will I receive my results?
We offer direct billing with all major UAE insurers; simply WhatsApp your policy card to +971 54 548 8731 for instant pre-approval. Samples collected Monday, Wednesday, or Friday before 9 AM report on Tuesday, Thursday, or Saturday respectively, allowing you to receive results within 48–72 hours for timely clinical decisions.
4. Are there any dietary or medication restrictions before providing a sample?
No fasting or dietary preparation is required for swab or sputum collection. However, inform the phlebotomist if you are currently taking antibiotics, antivirals, or immunosuppressants, as these may affect microbial detection sensitivity. Continue all prescribed medications unless otherwise instructed by your treating physician.
UAE Regulatory & Data Privacy Adherence
Regulatory & Privacy Compliance Framework
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for the secure collection, processing, and storage of patient health information. All clinical data are encrypted at rest and in transit, stored exclusively on UAE-based servers, and accessible only to authorised medical personnel under strict confidentiality protocols. Laboratory information management systems adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring interoperability, audit trails, and patient consent management. Clinical safety and patient consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability. The facility holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and is licensed by the Dubai Health Authority under facility number 1143.
Clinical & Logistical Metadata
| Test Name | Respiratory Comprehensive Panel |
| Price (AED) | 2,700 AED |
| Turnaround Time | 48–72 Hours (Mon-Wed-Fri Batch Processing) |
| Sample Type / Matrix | Throat/Nasal Swab, Sputum, Bronchoalveolar Lavage (BAL) |
| Methodology Used | Multiplex qPCR + Whole Genome Sequencing (WGS) |
| ICD-10-CM Code | J06.9 |
| LOINC Code | 100384-2 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians